NESIRITIDE (NATRECOR)

Course overview

Nesiritide is U.S. FDA-approved to treat acutely decompensated heart failure in adults with dyspnea at rest or with minimal activity (New York Heart Association [NYHA] class IV). It must be used cautiously in patients with severe heart failure whose renal function might depend on the renin-angiotensin-aldosterone system, or with systolic blood pressure of 90–100 mm Hg. This continuing education module is designed to give the reader/learner an increased understanding of nesiritide. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.